The Synergistic Use of IL-15 and IL-21 for the Generation of NK Cells From CD3/CD19-Depleted Grafts Improves Their ex vivo Expansion and Cytotoxic Potential Against Neuroblastoma: Perspective for Optimized Immunotherapy Post Haploidentical Stem Cell Transplantation.

MLA

Heinze, Annekathrin, et al. “The Synergistic Use of IL-15 and IL-21 for the Generation of NK Cells From CD3/CD19-Depleted Grafts Improves Their Ex Vivo Expansion and Cytotoxic Potential Against Neuroblastoma: Perspective for Optimized Immunotherapy Post Haploidentical Stem Cell Transplantation.” Frontiers in Immunology, vol. 10, Dec. 2019, p. 2816. EBSCOhost, https://doi.org/10.3389/fimmu.2019.02816.

APA

Heinze, A., Grebe, B., Bremm, M., Huenecke, S., Munir, T. A., Graafen, L., Frueh, J. T., Merker, M., Rettinger, E., Soerensen, J., Klingebiel, T., Bader, P., Ullrich, E., & Cappel, C. (2019). The Synergistic Use of IL-15 and IL-21 for the Generation of NK Cells From CD3/CD19-Depleted Grafts Improves Their ex vivo Expansion and Cytotoxic Potential Against Neuroblastoma: Perspective for Optimized Immunotherapy Post Haploidentical Stem Cell Transplantation. Frontiers in Immunology, 10, 2816. https://doi.org/10.3389/fimmu.2019.02816

Chicago

Heinze, Annekathrin, Beatrice Grebe, Melanie Bremm, Sabine Huenecke, Tasleem Ah Munir, Lea Graafen, Jochen T Frueh, et al. 2019. “The Synergistic Use of IL-15 and IL-21 for the Generation of NK Cells From CD3/CD19-Depleted Grafts Improves Their Ex Vivo Expansion and Cytotoxic Potential Against Neuroblastoma: Perspective for Optimized Immunotherapy Post Haploidentical Stem Cell Transplantation.” Frontiers in Immunology 10 (December): 2816. doi:10.3389/fimmu.2019.02816.